Aspirin and Extended - Release Dipyridamole

FDA Drug Profile — Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg

Drug Details

Generic Name
Aspirin and Extended - Release Dipyridamole
Brand Names
Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg
Application Number
ANDA207944
Sponsor
Endo USA, Inc.
NDC Codes
2
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
ASPIRIN, DIPYRIDAMOLE

Indications and Usage

1 INDICATIONS AND USAGE Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and Extended-Release Dipyridamole Capsule is a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )